Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|14|1848-1861

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.14, 2015-04, pp. : 1848-1861

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transition Metal Based Anticancer Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 5, 2011-03 ,pp. : 521-542

Bentham Science Publishers

Access to resources Recommend Favorite

Alkaloid-Metal Based Anticancer Agents

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 17, 2013-09 ,pp. : 2104-2115

Bentham Science Publishers

Access to resources Recommend Favorite

A novel screening approach to the modulation of unfavourable human serum albumin (HSA)/drug interactions

By Bhagavan N.V.   Petersen C.E.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 155-157

Informa Healthcare

Access to resources Recommend Favorite

Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 3, 2011-03 ,pp. : 214-224

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin

By  

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1866-1888

Bentham Science Publishers

Access to resources Recommend Favorite